| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/13/1992 | EP0484411A1 Prevention of internal initiation |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0484369A1 Modified bioluminescent proteins and their use |
| 05/13/1992 | EP0484325A1 Azido-substituted octopamine agonists and the use thereof to control invertebrate pests |
| 05/13/1992 | EP0446299A4 Method for site-specifically incorporating unnatural amino acids into proteins |
| 05/12/1992 | US5112961 Granulocyte-macrophage colony stimulating factor |
| 05/12/1992 | US5112955 Incubation plasminogen activator inhibitor with vitronectin in the presence of arginine and a carrier protein albumin or globulin |
| 05/12/1992 | US5112954 Antibodies specific for cancer cells |
| 05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
| 05/12/1992 | US5112952 Composition and method for isolation and purification of Immunoglobulin M |
| 05/12/1992 | US5112951 Separation of anti-metal chelate antibodies |
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112949 Method of and apparatus for separating proteins |
| 05/12/1992 | US5112948 Methods and compositions for inducing monocyte cytotoxicity |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112812 Peptide preparation, a process for producing it and use of the peptide preparation |
| 05/12/1992 | US5112811 Sdk peptides and therapeutic compositions containing them |
| 05/12/1992 | US5112809 CRF analogs |
| 05/12/1992 | US5112808 Alkylated hormone-releasing peptides and method of treatig mammals therewith |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | US5112756 Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112744 Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase |
| 05/12/1992 | US5112608 Use of protease nexin-I to mediate wound healing |
| 05/12/1992 | US5112606 Method of producing antibodies using colloidal metal as carrier |
| 05/12/1992 | CA1300533C Sterol regulatory elements |
| 05/12/1992 | CA1300501C Ovulation treatment |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | WO1992008801A1 Bridging antibody fusion constructs |
| 05/10/1992 | WO1992008793A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2095842A1 Bridging antibody fusion constructs |
| 05/10/1992 | CA2095635A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/09/1992 | WO1992008736A1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
| 05/09/1992 | CA2255396A1 Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism |
| 05/09/1992 | CA2055149A1 Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides |
| 05/08/1992 | WO1992008795A1 Expression of malaria polypeptides |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | EP0593757A4 Method for obtaining polypeptides in a cell-free system. |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095540A1 Expression of malaria polypeptides |
| 05/08/1992 | CA2055145A1 Dna encoding a protein which binds to the enhancer of .alpha.-fetoprotein gene |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | DE4034982A1 New peptide(s) corresponding to part of HCV C-100-3 construct - useful in vaccines and in binding assays, e.g. to distinguish between acute and chronic infection |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
| 05/06/1992 | WO1992007879A1 Biological active material covalently immobilized on to azlactone-functional polymeric supports and method for preparing it |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483911A2 Chicken anemia virus vaccine and diagnostic reagent |
| 05/06/1992 | EP0483643A2 Use of macrophage colony-stimulating factor in the treatment of cachexia |
| 05/06/1992 | EP0483509A1 Synthetic gene coding for human parathyroid hormone |
| 05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
| 05/06/1992 | EP0483304A1 Method of inactivation of viral and bacterial blood contaminants |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483271A1 Peptides containing diamino-glycols as transition-state mimics. |
| 05/06/1992 | EP0483261A1 Hirudin peptide derivatives |
| 05/06/1992 | EP0483249A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0483143A1 Membrane affinity apparatus and purification methods related thereto. |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/06/1992 | CN1060785A Natural anti-cancer leukonuclein made from animal spleens |
| 05/06/1992 | CA2093641A1 Biologically active material covalently immobilized with high bound specific biological activity and method of preparing same |
| 05/05/1992 | US5110920 Human leukocyte antigen; genotyping |
| 05/05/1992 | US5110913 Ion exchanging with sulfopropyl agarose, washing at slightly higher pH, elution at still higher pH |
| 05/05/1992 | US5110912 Purification of il-2-containing hybrid compounds |
| 05/05/1992 | US5110909 Both covalent and ionic bonding with ligand attached to polymer |
| 05/05/1992 | US5110908 Haemophilus influenzae peptides and proteins |
| 05/05/1992 | US5110907 Factor viii complex purification using heparin affinity chromatography |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110905 Activated Bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene |
| 05/05/1992 | US5110904 Lhrh analogs |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110730 Human tissue factor related DNA segments |
| 05/05/1992 | US5110729 Method of producing peptides using baculovirus vectors in cultured cells |
| 05/05/1992 | US5110728 Acyl carrier protein - DNA sequence and synthesis |
| 05/05/1992 | US5110589 Antigen from surface of Treponema hyodysenteriae |
| 05/05/1992 | US5110588 Composite salmonella E. coli, Vibrio cholerae vaccine strains |
| 05/05/1992 | US5110587 Immunogenic composition comprising synthetically modified vaccinia virus |
| 05/05/1992 | CA1300313C2 Amino acid derivatives |
| 05/05/1992 | CA1300052C Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof |
| 05/05/1992 | CA1300010C Hepatocyte growth factor |
| 05/05/1992 | CA1300008C Acid lyophilised pharmaceutical formulation of tissue plasminogen activator |
| 05/03/1992 | WO1992007870A1 Platelet aggregation inhibitors |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 05/03/1992 | CA2092315A1 Platelet aggregation inhibitors |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 05/01/1992 | CA2054542A1 Chicken anemia virus vaccine and diagnostic |
| 04/30/1992 | WO1994007913A1 Peptide antagonists of sh2 binding and therapeutic uses thereof |
| 04/30/1992 | WO1992007268A1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
| 04/30/1992 | WO1992007267A1 A synthetic peptide and its uses |
| 04/30/1992 | WO1992007265A1 Selective peptide labeling with hydrogen isotopes |